eClinical Solutions Market

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022

Report Code: HIT 2208 Apr, 2017, by marketsandmarkets.com

[163 Pages Report] eClinical solutions market is estimated to reach 7.61 Billion by 2022, at a CAGR of 12.4% during the forecast period (2017-2022).

The adoption of novel software solutions during clinical research and rising government funding to support clinical trials are key factors fueling the growth of the market. Furthermore, increased outsourcing of clinical trial processes by industrial researchers to contract research organizations (CROs) offers growth opportunities for market players.

The electronic data capture (EDC) and clinical data management system (CDMS) segment accounted for the largest share of the global market in 2016. The electronic clinical outcome assessment (eCOA) segment is expected to achieve the highest CAGR during the forecast period. The increasing demand for eDiaries in clinical studies to collect patient self-reports by major pharmaceutical companies and the use of mobile and digital technologies are driving the growth of this market segment.

Emerging markets including China, South Korea, Taiwan, and India are attractive destinations for outsourcing clinical trials due to the presence of a large patient population and the low operating cost of conducting clinical trials in these countries. Less stringent regulatory guidelines compared to developed nations, shortage of trial volunteers in Europe and North America, and the growing number of life science research companies and CROs are key factors propelling the demand for eClinical solutions in these emerging markets. In order to leverage the high growth opportunities, leading market players are expanding their presence in these nations.

As of 2016, Oracle Corporation (U.S.) held the leadership position in the eClinical solutions market. Over the past three years, the company has adopted partnerships, agreements, and collaborations and product launches, enhancements, and deployments as key business strategies to ensure its dominance. Medidata Solutions, Inc. (U.S.) PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), MaxisIT Inc. (U.S.), Bio-Optronics, Inc. (U.S.), eClinical Solutions, Inc. (U.S.), Merge Healthcare Incorporated (U.S.), and OmniComm Systems, Inc. (U.S.) are some of the other key players in this market.

Growing adoption of novel software solutions in clinical research and increasing regulatory requirements are expected to drive the eClinical solutions market growth

The eClinical solutions market size is projected to reach USD 7,606.6 Million by 2022, mainly due to the increasing operational costs and regulatory requirements associated with clinical research studies, growing adoption of novel software solutions during clinical research, rising government funding & grants to support clinical trials, need for improved data standardization, increasing R&D expenditure by pharma-biotech companies with augmented IT budget for drug development pipeline, and growing customer base for eClinical solutions. 

eClinical Solutions Market

Leading eClinical solutions providers are fosueing on partnerships, agreements, and collaborations strategy to strengthen their position

Companies involved in eClinical solutions market are focusing on partnerships, agreements, and collaborations as their key growth strategy, to maintain their position in the market and strengthen their revenue base. Companies also aim to differentiate themselves in the highly competitive eClinical solutions market by expanding their eClinical solutions portfolios in accordance with industry trends and client needs.

As of 2015, Oracle Corporation (US) held the leadership position in the eClinical solutions market. Over the past three years, the company has adopted new product launches, product approvals, product enhancements; strategic acquisitions and agreements as its key business strategies to ensure its global dominance in this market. The other key players in the market include Medidata Solutions, Inc. (US), PAREXEL International Corporation (US), and BioClinica, Inc. (US), OmniComm Systems, Inc. (US), DATATRAK International Inc. (US), ERT (US), Merge Healthcare Incorporated (US), CRF Health (US), and eClinical Solutions, Inc. (US) among others

eClinical Solutions Market Dynamics

eClinical Solutions Market Drivers

  • Increasing operational costs and regulatory requirements associated with clinical research studies
  • Growing adoption of novel software solutions in clinical research
  • Rising government funding & grants to support clinical trials
  • Growing adoption of eClinical solutions for improved data standardization
  • Increasing R&D expenditure by pharma-biotech companies with augmented it expenditure allocations for drug development pipeline
  • Growing customer base for eClinical solutions

eClinical Solutions Market Restraints

  • High implementation costs associated with eClinical solutions
  • Dearth of skilled professionals for operating eClinical solutions
  • Limited awareness among researchers related to advantages of eClinical solutions

eClinical Solutions Market Opportunities

  • Increasing clinical research activities in emerging Asian countries
  • Increased outsourcing of clinical trial processes by industrial researchers to CROs
  • Rising number of clinical trials, especially across emerging countries
  • Shift from manual data interpretation to real-time data analysis during clinical studies

eClinical Solutions Market Challenges

  • Limited adoption of eClinical solutions in developing nations
  • Software reliability
  • Patient privacy

Target Audience for eClinical Solutions Market

  • Healthcare IT Service Providers
  • eClinical Solution Vendors
  • Clinical Research Organizations
  • Pharmaceutical/Biopharmaceutical Companies
  • Research and Development (R&D) Companies
  • Business Research and Consulting Service Providers
  • Medical Research Laboratories
  • Academic Medical Centers/Universities/Hospitals
  • Venture capitalists and other government funding organizations
  • Market research and consulting firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the eClinical Solutions Market Report

This report categorizes the eClinical solutions market into the following segments:

eClinical Solutions Market, by Product

  • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
  • Clinical Trial Management Systems (CTMS) 
  • Clinical Analytics Platform 
  • Randomization and Trial Supply Management (RTMS)
  • Clinical Data Integration Platform
  • Electronic Clinical Outcome Assessment (eCOA)
  • Safety Solutions
  • Electronic Trail Master Files (eTMF)
  • Regulatory Information Management Solutions (RIMS)
  • Others (Coding Systems, Institutional Review Board Systems, and Core Lab Integration Solutions)

By Delivery Mode

  • Web-hosted (On-demand)
  • Licensed Enterprise (On-premise)
  • Cloud-based (SaaS)

By Clinical Trial Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations
  • Consulting Service Companies
  • Medical Device Manufacturers
  • Hospitals
  • Academic Research Institutions

By Region

  • North America
    • U.S.
    • Canada
  • Europe
  • Asia-Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies in the eClinical solutions market

Contract Research Organizations (CROs) Market Segmentation by Clinical Trial Phase

  • Contract research organizations (CROs) market segmentation by clinical trial phase (including Phase I, Phase II, Phase III, and Phase IV clinical trials)

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Key Questions

  • Technological advancements such as ‘cloud computing’ and ‘real-time data analysis’ are expected to fuel the market demand for eClinical solutions among end users. What would be other factors impacting the growth of eClinical solution market? 
  • eClinical solutions market is a highly competitive market with presence of several tier 1, 2, and 3 companies. What are key challenges faced by emerging market players to enter eClinical solutions market?
  • Cloud-based (SAAS) solutions are fast growing segment in the eClinical solution market. What revenue impact will it have on the overall eClinical solutions industry during the forecast period?
  • What are the major revenue impacting eClinical solutions offering high growth potential to the industry players? Where will these solutions lead the eClinical solutions market in upcoming 4-5 years?

The eClinical solutions market is estimated to reach 7.61 Billion by 2022, at a CAGR of 12.4% within the forecast period of 2017 to 2022. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and increasing R&D expenditure by pharma-biotech companies with augmented IT budgets for drug development are some of the major driving factors for the global market. However, the low adoption rate in certain geographies due to a lack of awareness related to the benefits of eClinical solutions is the major factor restraining the growth of this market.

The web-based delivery mode segment commanded the largest share of the global market. A number of factors such as easy user access, reductions in cost, and faster retrieval of data are responsible for its prominent market share. The cloud-based delivery mode segment is estimated to register the highest growth rate during the forecast period. The ease of integration, quicker deployment, and flexible scalability with a fixed monthly fee offered by cloud-based models are expected to drive the demand for these solutions.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America dominated the global market; the market in Asia-Pacific is expected to grow at the highest CAGR. This is primarily attributed to the increasing outsourcing of clinical trials by large pharmaceutical and biopharmaceutical organizations to developing Asia-Pacific countries, growth in government funding to support clinical research, presence of less stringent regulatory guidelines compared to developed nations to conduct clinical trials, presence of a large patient base, and faster patient recruitment for clinical trials in the region.

eClinical Solutions Market

Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.), PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), eClinical Solutions, Inc. (U.S.), MaxisIT Inc. (U.S.), Bio-Optronics, Inc. (U.S.), Merge Healthcare Incorporated (U.S.), and OmniComm Systems, Inc. (U.S.) are some key players operating in the eClinical solutions market.

Partnerships, agreements, and collaborations are key growth strategies adopted by major players to enhance their positions in this market. Strategies such as product launches, enhancements, and deployments; mergers, and acquisitions; and geographic expansions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the global market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Major Market Stakeholders

2 Research Methodology (Page No. - 19)

    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
                    2.2.1.1 Bottom-Up Approach
                    2.2.1.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions
3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 34)

    4.1 Eclinical Solutions: Market Overview
    4.2 By Product, 2015 vs 2015 vs 2022 (USD Million)
    4.3 Regional Analysis: By Delivery Mode (2016)
    4.4 By Clinical Trial Phase (2017 vs 2022)
    4.5 Regional Analysis: By End User (2017–2022)

5 Market Overview (Page No. - 38)

    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Major Market Drivers
                    5.2.1.1 Increasing Operational Costs and Regulatory Requirements Associated With Clinical Research Studies
                    5.2.1.2 Growing Adoption of Novel Software Solutions in Clinical Research
                    5.2.1.3 Rising Government Funding & Grants to Support Clinical Trials
                    5.2.1.4 Growing Adoption of Eclinical Solutions for Improved Data Standardization
                    5.2.1.5 Increasing R&D Expenditure By Pharma-Biotech Companies With Augmented It Expenditure Allocations for Drug Development Pipeline
                    5.2.1.6 Growing Customer Base for Eclinical Solutions
           5.2.2 Major Market Restraints
                    5.2.2.1 High Implementation Costs Associated With Eclinical Solutions
                    5.2.2.2 Dearth of Skilled Professionals for Operating Eclinical Solutions
                    5.2.2.3 Limited Awareness Among Researchers Related to Advantages of Eclinical Solutions
           5.2.3 Key Growth Opportunities
                    5.2.3.1 Increasing Clinical Research Activities in Emerging Asian Countries
                    5.2.3.2 Increased Outsourcing of Clinical Trial Processes By Industrial Researchers to Cros
                    5.2.3.3 Rising Number of Clinical Trials, Especially Across Emerging Countries
                    5.2.3.4 Shift From Manual Data Interpretation to Real-Time Data Analysis During Clinical Studies
           5.2.4 Major Market Challenges
                    5.2.4.1 Limited Adoption of Eclinical Solutions in Developing Nations
                    5.2.4.2 Software Reliability
                    5.2.4.3 Patient Privacy

6 eClinical Solutions Market, By Product (Page No. - 46)

    6.1 Introduction
    6.2 Electronic Data Capture and Clinical Data Management Systems
    6.3 Clinical Trial Management Systems
    6.4 Clinical Analytics Platforms
    6.5 Randomization and Trial Supply Management
    6.6 Clinical Data Integration Platforms
    6.7 Electronic Clinical Outcome Assessment Solutions
    6.8 Safety Solutions
    6.9 Electronic Trial Master File Systems
    6.10 Regulatory Information Management Solutions
    6.11 Other Eclinical Solutions

7 eClinical Solutions Market, By Delivery Mode (Page No. - 63)
    7.1 Introduction
    7.2 Web-Hosted (On-Demand) Solutions
    7.3 Licensed Enterprise (On-Premise) Solutions
    7.4 Cloud-Based (SaaS) Solutions

8 eClinical Solutions Market, By Clinical Trial Phase (Page No. - 69)
    8.1 Introduction
    8.2 Phase I Clinical Trials
    8.3 Phase II Clinical Trials
    8.4 Phase III Clinical Trials
    8.5 Phase IV Clinical Trials

9 eClinical Solutions Market, By End User (Page No. - 76)
    9.1 Introduction
    9.2 Pharmaceutical and Biopharmaceutical Companies
    9.3 Contract Research Organizations
    9.4 Consulting Service Companies
    9.5 Medical Device Manufacturers
    9.6 Hospitals
    9.7 Academic Research Institutes

10 eClinical Solutions Market, By Region (Page No. - 85)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
     10.4 Asia-Pacific
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 110)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Situation and Trends
             11.3.1 Agreements, Partnerships, and Collaborations
             11.3.2 Product Deployments
             11.3.3 Product Launches & Product Enhancements
             11.3.4 Mergers & Acquisitions
             11.3.5 Expansions
             11.3.6 Other Strategies

12 Company Profiles (Page No. - 117)
     12.1 Introduction
             12.1.1 Geographic Benchmarking
     12.2 Oracle Corporation
             12.2.1 Business Overview
             12.2.2 Products Offered
             12.2.3 Recent Developments (2013-2017)
             12.2.4 MnM View
     12.3 Medidata Solutions, Inc.
             12.3.1 Business Overview
             12.3.2 Products Offered
             12.3.3 Recent Developments (2013-2017)
             12.3.4 MnM View
     12.4 Parexel International Corporation
             12.4.1 Business Overview
             12.4.2 Products Offered
             12.4.3 Recent Developments (2013-2017)
             12.4.4 MnM View
     12.5 Bioclinica, Inc. (A Subsidiary of Cinven)
             12.5.1 Business Overview
             12.5.2 Products Offered
             12.5.3 Recent Developments (2013-2017)
             12.5.4 MnM View
     12.6 Datatrak International, Inc.
             12.6.1 Business Overview
             12.6.2 Products Offered
             12.6.3 Recent Developments (2013-2017)
     12.7 CRF Health
             12.7.1 Business Overview
             12.7.2 Products Offered
             12.7.3 Recent Developments (2013-2017)
     12.8 ERT Clinical
             12.8.1 Business Overview
             12.8.2 Products Offered
             12.8.3 Recent Developments (2013-2017)
     12.9 Merge Healthcare Incorporated
             12.9.1 Business Overview
             12.9.2 Products Offered
             12.9.3 Recent Developments (2013-2017)
     12.10 Omnicomm Systems, Inc.
             12.10.1 Business Overview
             12.10.2 Products Offered
             12.10.3 Recent Developments (2013-2017)
     12.11 Maxisit Inc.
             12.11.1 Business Overview
             12.11.2 Products Offered
             12.11.3 Recent Developments (2013-2017)
     12.12 Bio-Optronics, Inc.
             12.12.1 Business Overview
             12.12.2 Products Offered
             12.12.3 Recent Developments (2013-2017)
     12.13 Eclinical Solutions, LLC.
             12.13.1 Business Overview
             12.13.2 Products Offered
             12.13.3 Recent Developments (2013-2017)

13 Appendix (Page No. - 155)
     13.1 Discussion Guide*
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports


List of Tables (72 Tables)

Table 1 U.S.: Indicative List of Life Science Startups Launched Between 2011 & 2015
Table 2 Global eClinical Solutions Market Size, By Product, 2015–2022 (USD Million)
Table 3 Global Electronic Data Capture and Clinical Data Management Systems Market Size, By Region, 2015–2022 (USD Million)
Table 4 North America: Electronic Data Capture and Clinical Data Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 5 Global Clinical Trial Management Systems Market Size, By Region, 2015–2022 (USD Million)
Table 6 North America: Clinical Trial Management Systems Market Size, By Country, 2015–2022 (USD Million)
Table 7 Global Clinical Analytics Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 8 North America: Clinical Analytics Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 9 Global Randomization and Trial Supply Management Solutions Market Size, By Region, 2015–2022 (USD Million)
Table 10 North America: Randomization and Trial Supply Management Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 11 Global Clinical Data Integration Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 12 North America: Clinical Data Integration Platforms Market Size, By Country, 2015–2022 (USD Million)
Table 13 Global Electronic Clinical Outcome Assessment Solutions Market Size, By Region, 2015–2022 (USD Million)
Table 14 North America: Electronic Clinical Outcome Assessment Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 15 Global Safety Solutions Market Size, By Region, 2015–2022 (USD Million)
Table 16 North America: Safety Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 17 Global Electronic Trial Master File Systems Market Size, By Region, 2015–2022 (USD Million)
Table 18 North America: Electronic Trial Master File Market Size, By Country, 2015–2022 (USD Million)
Table 19 Global Regulatory Information Management Solutions (Rims) Market Size, By Region, 2015–2022 (USD Million)
Table 20 North America: Global Regulatory Information Management Solutions (Rims) Market Size ,By Country, 2015–2022 (USD Million)
Table 21 Global Other Market Size, By Region, 2015–2022 (USD Million)
Table 22 North America: Other Market Size, By Country, 2015–2022 (USD Million)
Table 23 Global Market Size, By Mode of Delivery, 2015–2022 (USD Million)
Table 24 Web-Hosted Market Size, By Region, 2015–2022 (USD Million)
Table 25 Licensed Enterprise Market Size, By Region, 2015–2022 (USD Million)
Table 26 Cloud-Based Market Size, By Region, 2015–2022 (USD Million)
Table 27 Global Market Size, By Clinical Trial Phase, 2015–2022 (USD Million)
Table 28 Market Size for Phase I Clinical Trials, By Region, 2015–2022 (USD Million)
Table 29 North America: Market Size for Phase I Clinical Trials, By Country, 2015–2022 (USD Million)
Table 30 Market Size for Phase II Clinical Trials, By Region, 2015–2022 (USD Million)
Table 31 North America: Market Size for Phase II Clinical Trials, By Country, 2015–2022 (USD Million)
Table 32 Market Size for Phase III Clinical Trials, By Region, 2015–2022 (USD Million)
Table 33 North America: Market Size for Phase III Clinical Trials, By Country, 2015–2022 (USD Million)
Table 34 Market Size for Phase IV Clinical Trials, By Region, 2015–2022 (USD Million)
Table 35 North America: Market Size for Phase IV Clinical Trials, By Country, 2015–2022 (USD Million)
Table 36 Global Market Size, By End User, 2015–2022 (USD Million)
Table 37 Market Size for Pharmaceutical and Biopharmaceutical Companies, By Region, 2015–2022 (USD Million)
Table 38 Key Strategic Alliances Between Cros and Pharma Companies (2011–2015)
Table 39 Market Size for Cros, By Region, 2015–2022 (USD Million)
Table 40 Market Size for Consulting Service Companies, By Region, 2015–2022 (USD Million)
Table 41 Market Size for Medical Device Manufacturers, By Region, 2015–2022 (USD Million)
Table 42 eClinical Solutions Market Size for Hospitals, By Region, 2015–2022 (USD Million)
Table 43 Market Size for Academic Research Institutes, By Region, 2015–2022 (USD Million)
Table 44 Global Market Size, By Region, 2015–2022 (USD Million)
Table 45 North America: Market Size, By Country, 2015-2022 (USD Million)
Table 46 North America: Market Size, By Product, 2015-2022 (USD Million)
Table 47 North America: Market Size, By Delivery Mode, 2015-2022 (USD Million)
Table 48 North America: Market Size, By Clinical Trial Phase, 2015-2022 (USD Million)
Table 49 North America: Market Size, By End User, 2015-2022 (USD Million)
Table 50 U.S.: Market Size, By Product, 2015-2022 (USD Million)
Table 51 U.S.: Market Size, By Clinical Trial Phase, 2015-2022 (USD Million)
Table 52 Canada: Market Size, By Product, 2015-2022 (USD Million)
Table 53 Canada: Market Size, By Clinical Trial Phase, 2015-2022 (USD Million)
Table 54 Ema-Approved Biosimilars
Table 55 Europe: Market Size, By Product, 2015–2022 (USD Million)
Table 56 Europe: Market Size, By Delivery Mode, 2015–2022 (USD Million)
Table 57 Europe: Market Size, By Clinical Trial Phase, 2015–2022 (USD Million)
Table 58 Europe: Market Size, By End User, 2015–2022 (USD Million)
Table 59 Asia-Pacific: Market Size, By Product, 2015–2022 (USD Million)
Table 60 Asia-Pacific: Market Size, By Delivery Mode, 2015–2022 (USD Million)
Table 61 Asia-Pacific: Market Size, By Clinical Trial Phase, 2015–2022 (USD Million)
Table 62 Asia-Pacific: Market Size, By End User, 2015–2022 (USD Million)
Table 63 RoW: Market Size, By Product, 2015–2022 (USD Million)
Table 64 RoW: Market Size, By Delivery Mode, 2015–2022 (USD Million)
Table 65 RoW: Market Size, By Clinical Trial Phase, 2015–2022 (USD Million)
Table 66 RoW: Market Size, By End User, 2015–2022 (USD Million)
Table 67 Agreements, Partnerships, and Collaborations (2013–2017)
Table 68 Product Deployments (2013–2017)
Table 69 Product Launches & Product Enhancements (2013–2017)
Table 70 Mergers & Acquisitions (2013–2017)
Table 71 Expansions (2013–2017)
Table 72 Other Strategies (2013–2017)


List of Figures (40 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 End-User Analysis Approach
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation
Figure 7 Global Market Size, By Product, 2017 vs 2022 (USD Million)
Figure 8 Global Market Size, By Delivery Mode, 2017 vs 2022 (USD Million)
Figure 9 Global Market Size, By Clinical Trial Phase, 2017 vs 2022 (USD Million)
Figure 10 Global Market Size, By End User, 2017 vs 2022 (USD Million)
Figure 11 Global Market Size, By Region, 2016 (USD Million)
Figure 12 Emerging Countries Offer High Growth Opportunities During the Forecast Period
Figure 13 EDC & CDMS Segment to Dominate the Global Market in 2022
Figure 14 Web-Hosted Delivery Mode Dominated the Market Across All Regional Segments in 2016
Figure 15 Phase III Clinical Trials to Dominate the Global Market During the Forecast Period
Figure 16 Contract Research Organizations Segment in Asia-Pacific is Expected to Witness the Highest Growth Rate
Figure 17 Global Market Drivers, Restraints, Opportunities, and Challenges
Figure 18 EDC and CDMS Segment Dominated the Global Market in 2016
Figure 19 North America is Estimated to Be the Largest Geographic Segment for EDC and CDMS Solutions Market in 2017
Figure 20 Asia-Pacific Projected to Be the Fastest-Growing Geographic Segment for CTMS Market During 2017-2022
Figure 21 North America is Estimated to Be the Largest Geographic Segment for Clinical Analytics Platforms Market in 2017
Figure 22 Asia-Pacific is Projected to Be the Fastest-Growing Geographic Segment for RTSM Solutions Market Till 2022
Figure 23 Web-Hosted Solutions to Dominate the Global Market in 2016
Figure 24 Phase III Trials to Witness Highest Demand Growth for Eclinical Solutions During the Forecast Period
Figure 25 Global Market Share, By End User (2016)
Figure 26 R&D Expenditure of Top 8 Pharmaceutical Companies, 2013 vs 2015 (USD Million)
Figure 27 Global Market Size, By Region, 2017 vs 2022 (USD Million)
Figure 28 North America: Market Snapshot
Figure 29 Europe: olutions Market Snapshot
Figure 30 Europe: Pharmaceutical R&D Expenditure, By Country (2012)
Figure 31 Asia-Pacific: Market Snapshot
Figure 32 RoW: Market Snapshot
Figure 33 Global Market Share, By Key Player, 2016
Figure 34 Geographic Revenue Mix of the Leading Market Players (2015)*
Figure 35 Oracle Corporation: Company Snapshot (2016)
Figure 36 Medidata Solutions, Inc.: Company Snapshot (2015)
Figure 37 Parexel International Corporation: Company Snapshot (2016)
Figure 38 Datatrak International, Inc.: Company Snapshot (2015)
Figure 39 Merge Healthcare Incorporated: Company Snapshot (2014)
Figure 40 Omnicomm Systems, Inc.: Company Snapshot (2015)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
HIT 2208
Published ON
Apr, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the eClinical Solutions Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved